SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000078003-22-000010
Filing Date
2022-02-11
Accepted
2022-02-11 16:26:42
Documents
2
Group Members
PFIZER VENTURES (US) LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G PYXIS ONCOLOGY pyxis_13gx2x22vf.htm SC 13G 68511
2 EX-99.1 JOINT FILING AGREEMENT pyxis_13gx2x22xexh99vf2.htm EX-99.1 6587
  Complete submission text file 0000078003-22-000010.txt   76714
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92951 | Film No.: 22621511
SIC: 2834 Pharmaceutical Preparations